RxDoctor Payments Data

Anil Sharma, MD

Gastroenterology · Portland, ORNPI 1497172530

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $11,000 of the $14,496 with a category attached, or 75.9%. Johnson & Johnson accounts for 92.6% of it on its own, with 9 other manufacturers making up the rest. 2025 is the largest year on record at $13,794, more than ten times the $125 reported in 2019. Among gastroenterology clinicians in OR with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$14,496in general payments, 2019–2025

Across 28 payments — averaging $517.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$13K
  • AbbVie$476
  • Janssen Scientific Affairs, LLC$250
  • Madrigal Pharmaceuticals$144
  • Medtronic$57
  • Takeda Pharmaceuticals U.S.A., Inc.$50
  • plus $90 from 4 others

What the payments were for

  • Speaking & faculty fees$11,00076%
  • Travel & lodging$2,10615%
  • Food & beverage$1,38910%

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$14,496 in reported general payments places this provider in the 95th percentile of 220 gastroenterology providers in Oregon.

See all gastroenterology providers in Oregon

Medicare billing

Part B allowed, 2024
$44,701
Medicare patients
87
Services billed
1,216

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
SutabSod Sulf/Pot Chloride/Mag Sulf13$1,999
Ondansetron OdtOndansetron61$270

Paid to pharmacies, not to this prescriber.

Other gastroenterology in Portland

See the full list for Oregon

Where these figures come from

Is this you, or does something look wrong? →